Amino substituted pyrimidine, pyrollopyridine and pyrazolopyrimidine derivatives useful as kinase inhibitors and in treating proliferative disorders and diseases associated with angiogenesis

Details for Australian Patent Application No. 2008296479 (hide)

Owner Dana Farber Cancer Institute

Inventors Choi, Hwan Guen; Sim, Taebo; Gray, Nathanael

Agent Davies Collison Cave

Pub. Number AU-A-2008296479

PCT Pub. Number WO2009/032694

Priority 60/966,449 28.08.07 US

Filing date 27 August 2008

Wipo publication date 12 March 2009

International Classifications

A01N 43/04 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/70 (2006.01) - Carbohydrates

Event Publications

8 April 2010 PCT application entered the National Phase

  PCT publication WO2009/032694 Priority application(s): WO2009/032694

4 November 2010 Amendment Made

  The nature of the amendment is: Delete all reference to Priority details US 60/966,449

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008296481-A water dispersible formulation for delivery of biocontrol fungi to reduce aflatoxin

2008296478-Synthetic apolipoprotein E mimicking polypeptides and methods of use